simvastatin
英式音标:[sɪm\'vɑ:steɪtɪn] 美式音标:[sɪm\'vɑsteɪtɪn]
simvastatin的意思释义 释义[医]系HMG辅酶A还原酶抑制剂,能降低男性血浆胆固醇和减少胆固
simvastatin怎么读
英式音标:[sɪm\'vɑ:steɪtɪn]
美式音标:[sɪm\'vɑsteɪtɪn]
simvastatin的意思释义
释义
[医]系HMG辅酶A还原酶抑制剂,能降低男性血浆胆固醇和减少胆固醇在动脉沉积;
英英释义
simvastatinn.an oral lipid-lowering medicine (trade name Zocor) administered to reduce blood cholesterol levels; recommended after heart attacks
同义词:Zocor
simvastatin用法及例句
例句参考
...Study of cholesterol lowering with simvastatin ...Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (...
RANDOMIZED TRIAL OF CHOLESTEROL-LOWERING IN 4444 PATIENTS WITH CORONARY-HEART-DISEASE - THE SCANDINAVIAN SIMVASTATIN SURVIVAL STUDY ...
Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of th...
High-Dose Atorvastatin vs Usual-Dose Simvastatin for Secondary Prevention After Myocardial Infarction: The IDEAL Study: A Randomized...
MRC/BHF Heart Protection Study of Cholesterol Lowering with Simvastatin in 20 536 High-Risk Individual: A Randomised Placebo-Control...
Early intensive vs. a delayed conservative simvastatin strategy in patients with acute coronary syndromes ☆
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and ...
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease.
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals
simvastatin相关例句
1. Objective To observe the influence of simvastatin on blood lipid and Creactive protein in patients with acute coronary syndrome.
目的:探讨早期应用辛伐他汀对急性冠脉综合征患者的血脂和C反应蛋白影响。
2. AIM To investigate the effect of fenofibrate and simvastatin on the serum free fatty acids of alcoholic fatty liver in rats.
目的研究非诺贝特和辛伐他汀对酒精性脂肪肝大鼠模型血清游离脂肪酸谱的影响。
3. Conclusion:The serum CK of rural patients with hyperlipemia increased temporarily during Simvastatin treatment. The physical labor strength during the treatment period will contribute to CK increase.
结论:农村高脂血症患者服用辛伐他汀会引起血清CK短暂性升高,在服药期间体力劳动强度将会影响CK的升高。
4. Simvastatin is sold as a single-ingredient generic medication and as the brand-name Zocor.
作为单一成分出售的辛伐他汀是非专利药,商品名为舒降之。
5. AIM: To probe the efficacy of simvastatin for lowering lipidemia in diabetic nephropathy with hyperlipidemia and protecting renal function.
目的:探索辛伐他汀对糖尿病肾病高脂血症降血脂疗效和保护肾功能的作用。
6. Objective Observe the blood lipid-reducing efficacy of the simvastatin on earlier stage of primary hyperlipaemia and acute coronary syndrome and the affection of ischemia event.
目的观察在原发高脂血症合并急性冠脉综合征早期应用辛伐他汀对降低血脂的疗效及缺血事件发生的影响。
7. I head for the kitchen and line up the pills he’s supposed to be taking: the alpha-blocker for prostate, the blood-pressure meds, the simvastatin for high cholesterol, the vitamins, the baby aspirin.
我去厨房,找出他该吃的那些药丸:前列腺用的甲型交感神经阻断剂,高血压药,高胆固醇服用的辛伐他汀,各种维他命,婴儿食用的阿司匹林。
8. Objective To investigate the influences of simvastatin on carotid artery Intima-media thickness(IMT)and carotid atherosclerotic plaque.
目的探讨辛伐他汀对颈动脉内膜-中膜厚度及颈动脉粥样硬化斑块的影响。
9. Conclusion: Simvastatin reveals the definite beneficial effect in treating the unstable angina and may get it in the early use.
结论:辛伐他汀在不稳定心绞痛治疗中,起着肯定的有益作用,并且早期应用可能即获益。
10. In fact, there were fewer all-cause and cardiovascular deaths in fenofibrate-treated patients than in patients treated with simvastatin alone.
实际上,单独使用非诺贝特比单独使用辛伐他汀病人死于多种原因以及心血管病的病人要少。
11. Objective: To verify the beneficial effect of simvastatin in the treatment of the unstable angina.
目的:探明辛伐他汀在不稳定心绞痛治疗中的有益作用。
12. Conclusion: We confirmed that simvastatin promote differentiation and capacity of mineralization of BMSC and contribute to the prevention and treatment of osteoporosis.
结论:辛伐他汀促进骨髓基质细胞的分化,提高其矿化能力,有助于骨质疏松症的防治。
13. Objective To discuss the val ue of simvastatin plus fenofibrate for the treatment of mixed hyperlipemia.
目的探讨辛伐他汀联合非诺贝特治疗混合性高脂血症的价值。
14. Objective: To investigate the effects of simvastatin on the renal tubular epithelial myofibroblast transdifferentiation in type 1 diabetic rat.
目的:观察辛伐他汀对实验性1型糖尿病大鼠肾小管上皮细胞转分化的作用。
15. Objective:To determine the contents of residual volatile organic solvents: methanol, ethanol, cyclo-hexane, toluene, N, N - dimethylformamide in simvastatin.
目的:测定辛伐他汀中残留有机溶剂甲醇、乙醇、环己烷、甲苯和N,N-二甲基甲酰胺的含量。
16. The over expression could be blocked by arecoline, PPVP, DMHPPP and simvastatin.
槟榔碱、PPVP、DMHPPP和辛伐他汀可以减轻其过量表达。
17. There was no significant change of vasodilation responding to nitroglycerin and brachial diameter in all groups after simvastatin therapy.
辛伐他汀治疗后肱动脉内径和肱动脉对硝酸甘油的反应均无显著改变。
18. Conclusion Simvastatin can inhibit the hypertrophy of cultured rat cardiac myocytes induced by serum, the mechanism of which might be related with the increase of PTEN expression.
结论辛伐他汀能够抑制血清诱导的心肌细胞肥大,升高PTEN表达水平可能是其分子生物学机制之一。
19. Conclusion Simvastatin and rosiglitazone can decrease serum level of lipids and exert anti-atherosclerotic effect by reducing the expression of CD40 and CD40L.
结论辛伐他汀与罗格列酮均能降低血脂,并通过降低巨噬细胞CD40和CD40L表达发挥抗动脉粥样硬化作用。
20. Conclusion Simvastatin can reduce the kidney hypertrophy index in the diabetic rats and it has renal protective effect on the diabetic rats.
结论辛伐他汀可以降低糖尿病大鼠肾肥大指数,对糖尿病肾脏病变有保护作用。
21. OBJECTIVE To study the dissolution rate in vitro of simvastatin pills.
目的探讨辛伐他汀滴丸的体外溶出速率。
22. Objective: To study the effects on lipid - lowing therapy of simvastatin.
前言:目的:探讨影响辛伐他汀降脂疗效的临床因素。
23. OBJECTIVE To explore the effect of simvastatin on myocardial hypertrophy and the expression of extracellular signal-regulated kinases (ERK) in spontaneously hypertensive rat (SHR).
目的探讨辛伐他汀对自发性高血压大鼠(SHR)心肌肥厚及细胞外信号调节激酶(ERK)的影响。
24. OBJECTIVE To investigate the effect of simvastatin on biochemical markers of bone formation in treating the patients with hyperlipidemia.
目的研究辛伐他汀治疗高脂血症对骨形成生化标志物的影响。
25. Objective: To understand the adverse effects of simvastatin and promote rational medication.
目的了解辛伐他汀的副作用,提倡合理用药。
26. OBJECTIVE To develop a method for the determination of Simvastatin in human plasma.
目的建立测定人血浆中辛伐他汀的方法。
27. Conclusion Atorvastatin could decrease the serum level of TC, LDL-C and TG and improve the brachial artery endothelial function, and its effects were similar to simvastatin.
结论阿托伐他汀能显著降低高胆固醇血症患者血清TC、LDL-C及TG和改善血管内皮功能,并且其作用与辛伐他汀相似。
28. Conclusion Atorvastatin could decrease the serum level of TC, LDL-C and TG and improve the brachial artery endothelial function, and its effects were similar to simvastatin.
结论阿托伐他汀能显著降低高胆固醇血症患者血清TC、LDL-C及TG和改善血管内皮功能,并且其作用与辛伐他汀相似。